This action might not be possible to undo. Are you sure you want to continue?
ALPHA STRATEGY : LONG PFC – SHORT REC
Strategy Buy PFC and sell REC on a rupee-neutral basis in anticipation of pair reaching to the target price ratio of 1.075. The currently price ratio is at 0.978 We recommend booking part profits at a ratio of 1.026, keeping a stop loss of 0.919. Fundamental View: Long PFC: Long PFC: Disbursement growth momentum continues and at the current run-rate of INR 75-80 bn per quarter would easily beat the guidance provided earlier. Margin: PFC has reported close to 4.1% margin in last quarter and expects the same to continue with positive upside The company has unhedged forex borrowings; with rupee appreciation should result in MTM profit of INR 600 mn in Q2 Short REC: The near trigger in stock price for REC has been increase in FII limit from 20% to 35%. However, in PFC still the float is only 10%.
October 22, 2010 Yogesh Radke +91-22-6620 3199 firstname.lastname@example.org Mehul Patel +91-22-4063 5556 Mehul.email@example.com
Margin: REC has seen margins improving from 4% in Q4FY10 to 4.6% in Q2FY10 and expect it to consolidate at these levels with negative bias. REC has access to capital gain exemption bond the benefit of which with new Direct tax Code will go away.
The traction is disbursements for REC is expected to be relatively lower compared to PFC. Valuation: Given the loan growth estimate of 28% CAGR over FY10-12 stock is trading close to 2.5x PB Vs PFC with similar operating matrix is trading close to 2.35x PB. PFC has approached RBI for infrastructure finance company status and funding access and advantage will be equal for both of them post this. Management has also indicated that it will tap capital markets in the early next year which would add to ~INR 20 in book value which will leads to further upside in valuation. Moreover FII window would be effectively utilized post this fund raising.
Edelweiss Research is also available on Bloomberg EDEL <GO>, Thomson First Call, Reuters and Factset. Edelweiss Securities Limited 1
00) 0.00) 0.0) standard deviations below its 60 day mean price ratio. 60 Day Z-Stat P rice Ratio P FC/RECLTD P R 60 Day M ean PFC / RECLTD 3.00 1.00 1.974 (3.074 Price Ratio 1.124 2.00 1.00) Edelweiss Securities Limited 2 .Pair Strategy:Mean Divergence Statistical View: Over the past 60 days. As a result the basket is trading near (1.00) (2.924 9-Jul-10 23-Jul-10 6-Aug-10 20-Aug-10 2-Apr-10 16-Apr-10 30-Apr-10 5-Feb-10 11-Jun-10 25-Jun-10 3-Sep-10 19-Feb-10 19-Mar-10 14-May-10 28-May-10 17-Sep-10 5-Mar-10 1-Oct-10 15-Oct-10 (4. PFC has underperformed REC as REC is up by 22% where as PFC is up by 14%.024 Z-Score (1.
00 2.586 Max Return Return Max Gain loss on on GEP* on AD# on GEP* GEP* 10.00 832.0% Status Closed Closed Closed Closed Closed Closed Closed Edelweiss Securities Limited 3 .38 0.00) -3.434 1.9% 15.26% -6.95 845.2% -6.0% 5.479 0.5% 16.0% 7.05) (0.00 437.479 0.18 1.50 249.372.00 404.53 0.00 263.0% 10.845 0.00 Close 0.622 Close Price 1.00 854.Pair Strategy:Mean Divergence Closed Trades No of Days trade open 26 28 16 9 7 4 3 ALPHA Strategy Update Start Date/ Closing Strategy Date Long LICHSGFIN 23-Jun-10 Short HDFC 28-Jun-10 21-Jun-10 Long ALBK 28-Jun-10 Short OBC 5-Jul-10 Long M&M 25-Jul-10 Short MARUTI 12-May-10 Long ITC Short HUL 24-Nov-08 Long Axis Bank Short Bank of India 18-Nov-08 Long AXIS BANK 21-Nov-08 Short HDFC BANK 17-Mar-09 Long HDFC BANK Short HDFC Entry Price 1.950.0% -0.5% -12.410.1% 126.96.36.1999.00 1.00 232.00 912.0% 7.008.5% 16.10% 2.00 1.952.3% 4.342 0.51 1.04) (0.00 273.5% 0.00 459.0% 11.00 332.1% 11.0% 19.5% 11.00 244.00 358.0% (0.664 0.491 0.00 236.00 1.00 Entry Ratio 0.114 1.0% 32.00 1.0% 0.00 629.00 188.00 2.00 406.00 163.0% 22.00 612.
Edelweiss Securities Limited 4 . have long or short positions in. and should consult his own advisors to determine the merits and risks of such investment. deflation or not?) Edelweiss Style Analysis: What's hot Enhanced Nifty: Nifty with an edge 01-Oct-10 01-Mar-10 13-Oct-10 Access the entire repository of Edelweiss Research on www. availability or use would be contrary to law. in whole or in part. group companies. Nevertheless. its holding company and associate companies are a full service. where such distribution. Edelweiss. The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities. country or other jurisdiction. agents or representatives shall be liable for any damages whether direct. portfolio management and brokerage group. Board: (91-22) 2286 4400. Edelweiss Securities Limited generally prohibits its analysts. firstname.lastname@example.org@edelcap. Copyright 2009 Edelweiss Research (Edelweiss Securities Ltd). We and our affiliates. copied. This document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. directors. and persons in whose possession this document comes.com nischal. The distribution of this document in certain jurisdictions may be restricted by law. state. Our research analysts and sales persons provide important input into our investment banking activities. and no part of his or her compensation was. group companies. Edelweiss is under no obligation to update or keep the information current. any such restrictions. any person or entity who is a citizen or resident of or located in any locality.com This document has been prepared by Edelweiss Securities Limited (Edelweiss). Edelweiss or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Each recipient of this document should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved). regulation or which would subject Edelweiss and affiliates/ group companies to any registration or licensing requirements within such jurisdiction. or use by.com +91 22 2286 4206 +91 22 6623 3411 Alternative Research Regular Products Daily Market Outlook (DMO) Earnings Style Analysis (ESA) Edelweiss Corporate Action Tracker (e CAT) Edelweiss Technical Reflection (ETR) Enhanced Nifty (e Nifty) hEDGE Insider Trades Pair Strategy Rollovers Analysis Factor Analyser (FA) Special Situation Products ADS Conversion Alpha Trades Buy Back Delisting De-Merger Directional (Long / Short) Merger Open Offer Option Trading Restructuring (Value Unlocking) Rights Arbitrage Secondary Offerings Spread Trade Date 15-Jul-09 Special Report Master Moves (Opportunities from Open offer. The information contained herein is from publicly available data or other sources believed to be reliable. for any purpose. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published. employees.com Pair Strategy:Mean Divergence Vikas Khemani Nischal Maheshwari Head Head Institutional Equities Research vikas. Reuters and Factset. Past performance is not necessarily a guide to future performance. Thomson First Call. persons reporting to analysts and their family members from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Analyst holding in the stock: Yes. directors.edelresearch. The information given in this document is as of the date of this report and there can be no assurance that future results or events will be consistent with this information. This information is strictly confidential and is being furnished to you solely for your information. The investment discussed or views expressed may not be suitable for all investors. Express Towers. delisting) Date 30-Sep-10 06-Sep-10 15-Oct-10 Monthly Report Rollover Analysis hEDGE: The alternative insights monthly FA: Factor Analyser Edelweiss Fund Insight – EFI 24-Sep-10 Edelweiss Vital Insights (US stares at a million dollar question. directly or indirectly related to specific recommendations or views expressed in this report. Neither Edelweiss nor any of its affiliates. but we do not represent that it is accurate or complete and it should not be relied on as such. indirect. and employees may: (a) from time to time. This report is not directed or intended for distribution to. This document is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Mumbai – 400 021. integrated investment banking. Nariman Point. is or will be. 14th Floor. officers. Email: research@edelcap. of company (ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as advisor or lender/borrower to such company (ies) or have other potential conflict of interest with respect to any recommendation and related information and opinions. Buy back. should inform themselves about and observe. The user assumes the entire risk of any use made of this information. This information is subject to change without any prior notice. special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information.Edelweiss Securities Limited. Edelweiss is committed to providing independent and transparent recommendation to its client and would be happy to provide any information in response to specific client queries. However. The disclosures of interest statements incorporated in this document are provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. Edelweiss reserves the right to make modifications and alterations to this statement as may be required from time to time. and buy or sell the securities thereof. All rights reserved Edelweiss Research is also available on Bloomberg EDEL <GO>.
This action might not be possible to undo. Are you sure you want to continue?
We've moved you to where you read on your other device.
Get the full title to continue reading from where you left off, or restart the preview.